Effects of aflibercept on primary RPE cells: toxicity, wound healing, uptake and phagocytosis

Different effects of intravitreally injected ranibizumab and aflibercept on retinal and choroidal tissues of monkey eyes

(2014) Sylvie Julien et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial

(2013) Usha Chakravarthy et al.   LANCET

Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials

(2013) Juan E. Grunwald et al.   OPHTHALMOLOGY

Actions of bevacizumab and ranibizumab on microvascular retinal endothelial cells: similarities and differences

(2012) Heidrun L Deissler et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Vectorial release of matrix metalloproteinases (MMPs) from porcine RPE-choroid explants following selective retina therapy (SRT): Towards slowing the macular ageing process

(2012) F. Treumer et al.   EXPERIMENTAL EYE RESEARCH

Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration

(2012) Jeffrey S. Heier et al.   OPHTHALMOLOGY

CURRENT KNOWLEDGE AND TRENDS IN AGE-RELATED MACULAR DEGENERATION

(2012) Raul Velez-Montoya et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

THE EFFECTS OF AFLIBERCEPT ON THE VIABILITY AND METABOLISM OF OCULAR CELLS IN VITRO

(2012) David A. Ammar et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Effect of VEGF and VEGF Trap on vascular endothelial cell signaling in tumors

(2011) Wiem Lassoued et al.   CANCER BIOLOGY & THERAPY

Defective photoreceptor phagocytosis in a mouse model of enhanced S-cone syndrome causes progressive retinal degeneration

(2011) Debarshi Mustafi et al.   FASEB JOURNAL

Quantifying FITC-Labeled Latex Beads Opsonized with Photoreceptor Outer Segment Fragments: An Easy and Inexpensive Method of Investigating Phagocytosis in Retinal Pigment Epithelium Cells

(2011) Alexa Klettner et al.   OPHTHALMIC RESEARCH

Deferoxamine mesylate is toxic for retinal pigment epithelium cellsin vitro, and its toxicity is mediated by p38

(2010) Alexa Klettner et al.   Cutaneous and Ocular Toxicology

Neovascular age-related macular degeneration: decision making and optimal management

(2010) S P Harding   EYE

Intracellular bevacizumab reduces phagocytotic uptake in RPE cells

(2010) Alexa Klettner et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Individual recurrence intervals after anti-VEGF therapy for age-related macular degeneration

(2010) Robert Hörster et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

SAFETY TESTING OF INDOCYANINE GREEN WITH DIFFERENT SURGICAL LIGHT SOURCES AND THE PROTECTIVE EFFECT OF OPTICAL FILTERS

(2010) JOST HILLENKAMP et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials

(2009) P Mitchell et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Intravitreal bevacizumab (Avastin) for age-related macular degeneration: a critical analysis of literature

(2009) S Jyothi et al.   EYE

Different properties of VEGF-antagonists: Bevacizumab but not Ranibizumab accumulates in RPE cells

(2009) Alexa Karina Klettner et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Treating Age-Related Macular Degeneration – Interaction of VEGF-Antagonists with their Target

(2009) A. Klettner et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY